James River Coal (JRCC) 'Sell' Maintained at Imperial Capital; Company Needs to Address Liquidity
Tweet Send to a Friend
Imperial Capital analyst Salix Pharmaceuticals reiterated an Underperform rating and $1 price target on James River Coal (NASDAQ: JRCC) following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
